Skip to content

Coyne Terrance P.

Reporting owner on Forms 3, 4 and 5, CIK 1814876.

Coyne Terrance P. reported on 1 issuer in 2 filings, the latest a Form 4 filed 2026-11-18.

Issuers

IssuerRoles in the latest filingFilingsLast filed
RPRX · Royalty Pharma plcCIK 1802768officer (EVP & CFO)22026-11-18

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-17S sold-14,751$68.30470Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-17S sold-9,835$68.30470Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-16S sold-135,249$68.868114,751Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-16S sold-90,165$68.8689,835Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-16S sold-7,122$68.8680Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 24,170Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 23,270Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 1,500Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 1,450Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-06C converted+150,000$0150,000Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-06C converted+100,000$0100,000Form 4
RPRX · Royalty Pharma plcLP interests in RPI US Partners 2019, LP, derivative2026-11-06C converted-15,000$0102,526Form 4
RPRX · Royalty Pharma plcLP interests in RPI US Partners 2019, LP, derivative2026-11-06C converted-10,000$0473,942Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares2026-11-04A granted+7,122$07,122Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 24,170Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 23,270Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 1,500Form 4
RPRX · Royalty Pharma plcClass A Ordinary Shares, holding 1,450Form 4
RPRX · Royalty Pharma plcLP interests in RPI US Partners 2019, LP, derivative, holding 43,350Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001814876-26-000032 Royalty Pharma plc2026-11-18
Form 4 0001814876-26-000029 Royalty Pharma plc2026-11-06